Oversubscribed Life Science REIT IPO raises £350m

£1 per share

Life Science REIT has successfully completed its IPO, raising gross proceeds of £350m, becoming the first London-listed real estate investment trust focused on UK life science properties.

New ordinary shares were issued at £1 each and the company has made an application for 350m shares to be admitted to AIM. It is expected the dealings will commence in the shares on 19 November, under the tickers LABS. UK Residential REIT contemplates options as it fails to hit target by deadline The company received applications exceeding the maximum £350m size of the issue and, as a result, a scaling-back exercise has been undertaken. Investors in Life Science REIT will have exposure to a diversified portfolio of properties across the UK, with particular focus on the "Golden Tr...